Attend PACK EXPO – this year’s can’t-miss event in Chicago, Oct 23-26.
Discover solutions from 2,000+ exhibitors to advance your operations and network with colleagues at PACK EXPO International.
REGISTER TODAY

New ‘Living Drug’ Gives Terminal Cancer Patients Hope

A new therapy called CAR-T is custom-tailored for patients and uses their own cells to fight terminal blood cancer.

CAR-T / Image: Gilead
CAR-T / Image: Gilead

Terminal cancer of the blood is a rare occurrence that is typically treated with chemotherapy, a long and unpleasant process. A recent BBC News article reported on a new treatment that is giving these terminal patients, of which there are roughly 200 a year, new hope for survival. The therapy is called CAR-T, and it’s a “living drug” that’s custom-made for each patient and uses their own cells.

Physicians remove T-cells from the patient’s blood, freeze them in liquid nitrogen, and send them to laboratories. There, the cells are genetically reprogrammed into “chimeric antigen receptor T-cells” (CAR-T cells) that destroy cancer, rather than bacteria and viruses. The manufacturing process produces millions of the modified cells and takes about a month. Long-term data on effectiveness isn’t available since the strategy is still new, but early results look promising.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub